Abstract:Funding Acknowledgements None. Background Hypertrophic cardiomyopathy (HCM) is the most frequently diagnosed inherited cardiomyopathy as well as the leading cause of sudden death in young people. Despite that, prompt diagnosis and prognosis of this condition are still challenging due to subtle progression and preserved left ventricular ejection fraction (LVEF) in most stages. Latest studies showed that myocardial strains could be the earliest indicator of function impairment and a good trait suggesting underlying fibrosis development. Purpose By applying the cardiac magnetic resonance (CMR) feature-tracking technique, our aim is to evaluate whether the divergence between the LVEF and global strains, apart from the strains themselves, could help predict the burden of myocardial fibrosis in HCM patients. Methods In this retrospective, cross-sectional study from June 2022 to June 2023, we included 35 HCM patients and 16 healthy controls with 3T-CMR. LVEF, left ventricular global longitudinal (LVGLS), circumferential (LVGCS), and radial (LVGRS) strains were derived from short-axis Cine images. To assess the divergence, ratios of LVEF to LVGLS, LVGCS, and LVGRS absolute values (namely EF-GLS, EF-GCS, and EF-GRS, respectively) were calculated. The ratios helped emphasise that a persisting high/normal LVEF and/or a lower strain magnitude would produce a larger discrepancy between these two variables. Fibrosis was assessed by LGE amount (%LGE to LV mass, threshold of +5 SD). Two-sample t-Test, linear and binary logistic regression were the main statistical tests used. Results The global strain measures all expressed notable impairment in HCM groups compared to healthy controls (LVGLS [-12.04±3.9 vs -19.42±2%, p<0.001]; LVGCS [-16.37±4.1 vs -19.3±2.1, p=0.002]; LVGRS [28.06±9.9 vs 33.8±6.5%, p=0.018] while sharing the same range of LVEF [59.09±9.9 vs 59.44±5.3, p=0.87). The ratios of EF-GLS, EF-GCS, and EF-GRS also showed statistically significant differences between the two groups. In the HCM group, LVGLS and EF-GLS ratio showed the strongest correlations with %LGE (r = 0.855 and r = 0.708, p<0.001). A regression equation can also be derived to estimate the amount of LGE from the EF-GLS ratio: %LGE = 3.967 EF-GLS - 0.22. To determine predictive power toward the severity of fibrosis, the EF-GLS ratio showed the best performance, in which a threshold of 4.96 had sensitivity and specificity of 73.7% and 93.8% to predict LGE ≥ 15% LV mass (Area Under the Curve [AUC]: 0.717; 95% CI: 0.521–0.913). Conclusion Our study demonstrated that the ratio of LVEF to LV global longitudinal strain exhibited a great capability to reflect LV dysfunction and predict myocardial fibrosis severity with good accuracy. Derived easily from the routine Cine-CMR image, this new deformation parameter has great potential to be used in clinical practice to better diagnose and manage hypertrophic cardiomyopathy.Clinical characteristics of groupsResults in graphs

Association of Electrocardiographic Markers with Myocardial Fibrosis As Assessed by Cardiac Magnetic Resonance in Different Clinical Settings

Identification of Fibrosis in Hypertrophic Cardiomyopathy: a Radiomic Study on Cardiac Magnetic Resonance Cine Imaging.

Performance of Cardiovascular Magnetic Resonance Strain in Patients with Acute Myocarditis

Electromechanical Relationship in Hypertrophic Cardiomyopathy

Predictive values of multiple non-invasive markers for myocardial fibrosis in hypertrophic cardiomyopathy patients with preserved ejection fraction

Myocardial Contraction Fraction as a Simple Marker of Disease Severity in Hypertrophic Cardiomyopathy

Predictive Value of Cardiac Magnetic Resonance Mechanical Parameters for Myocardial Fibrosis in Hypertrophic Cardiomyopathy with Preserved Left Ventricular Ejection Fraction.

Relationship between fragmented QRS complexes on the routine electrocardiogram and myocardial fibrosis/scar in patients with hypertrophic cardiomyopathy

Detection and evaluation of myocardial fibrosis in Eisenmenger syndrome using cardiovascular magnetic resonance late gadolinium enhancement and T1 mapping

Myocardial Disarray and Fibrosis across Hypertrophic Cardiomyopathy Stages Associate with ECG Markers of Arrhythmic Risk

Comparison of Magnetic Resonance Analysis of Myocardial Scarring with Biomarker Release Following S-T Elevation Myocardial Infarction.

Myocardial Late Gadolinium Enhancement (LGE) in Cardiac Magnetic Resonance Imaging (CMR)—An Important Risk Marker for Cardiac Disease

Divergence between left ventricular ejection fraction and global longitudinal strain by cardiac magnetic resonance as a new predictor of myocardial fibrosis burden in hypertrophic cardiomyopathy

Cardiometabolic biomarker patterns associated with cardiac MRI defined fibrosis and microvascular dysfunction in patients with heart failure with preserved ejection fraction

Utility of Cardiac Magnetic Resonance in Assessing Arrhythmic Risk in Patients With Nonischemic Cardiomyopathy Undergoing Biventricular Pacing

Electrocardiographic associations with myocardial fibrosis among sudden cardiac death victims

The Value of Myocardial Fibrosis Parameters Derived from Cardiac Magnetic Resonance Imaging in Risk Stratification for Patients with Hypertrophic Cardiomyopathy

Detecting Regional Fibrosis in Hypertrophic Cardiomyopathy: The Utility of Myocardial Strain Based on Cardiac Magnetic Resonance.

Focal ischemic myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy

Characterisation of Left Ventricular Myocardial Fibrosis in Adult Congenital Heart Disease by Contrast and Deformation Echocardiography Validated by CMR

Myocardial Fibrosis Evaluated by Diffusion-Weighted Imaging and Its Relationship to 3D Contractile Function in Patients with Hypertrophic Cardiomyopathy.